Weiyi Sun1, Megan S Rice2,3, Min K Park4, Ock K Chun5, Melissa M Melough5, Hongmei Nan6,7, Walter C Willett3,8,9, Wen-Qing Li1,4, Abrar A Qureshi1,4, Eunyoung Cho1,3,4. 1. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. 2. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA. 3. Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA. 4. Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, USA. 5. Department of Nutritional Sciences, University of Connecticut, Storrs, CT, USA. 6. Department of Epidemiology, Richard M Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA. 7. IU Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA. 8. Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA. 9. Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: In prior studies, higher citrus consumption was associated with higher risk of cutaneous malignant melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). Furocoumarins, compounds with phototoxicity and photocarcinogenicity in citrus, may be responsible for the association. OBJECTIVES: The objective of the study was to investigate the association between furocoumarin intake and skin cancer risk. METHODS: A total of 47,453 men from the Health Professionals Follow-Up Study (HPFS) and 75,291 women from the Nurses' Health Study (NHS) with diet data collected every 2-4 y in the 2 prospective cohort studies were included. A furocoumarin food composition database for 7 common furocoumarins [bergaptol, psoralen, 8-methoxypsoralen, bergapten, 6',7'-dihydroxybergamottin (6'7'-DHB), epoxybergamottin, and bergamottin] was developed and used to calculate participants' cumulative average and energy-adjusted furocoumarin intake. Multivariate HRs and 95% CIs of the associations between furocoumarin intake and skin cancer risk were estimated using Cox proportional hazards models. Analyses were performed separately in each cohort as well as pooled using a fixed-effects model. RESULTS: Throughout follow-up (1984-2012 in the NHS and 1986-2012 in the HPFS), we identified 1593 melanoma, 4066 SCC, and 28,630 BCC cases. Higher intake of total furocoumarins was associated with an increased risk of BCC; the pooled HR comparing the top with the bottom quintile was 1.16 (95% CI: 1.11, 1.21; P-trend = 0.002). Higher intakes of bergaptol, bergapten, 6'7'-DHB, and bergamottin were also significantly associated with increased BCC risk. No significant associations were found between intake of total furocoumarins and the risks of SCC or melanoma. CONCLUSIONS: Intakes of total furocoumarins as well as some individual furocoumarins were associated with an increased risk of skin cancer, especially BCC, in 2 cohorts of US health professionals.
BACKGROUND: In prior studies, higher citrus consumption was associated with higher risk of cutaneous malignant melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). Furocoumarins, compounds with phototoxicity and photocarcinogenicity in citrus, may be responsible for the association. OBJECTIVES: The objective of the study was to investigate the association between furocoumarin intake and skin cancer risk. METHODS: A total of 47,453 men from the Health Professionals Follow-Up Study (HPFS) and 75,291 women from the Nurses' Health Study (NHS) with diet data collected every 2-4 y in the 2 prospective cohort studies were included. A furocoumarin food composition database for 7 common furocoumarins [bergaptol, psoralen, 8-methoxypsoralen, bergapten, 6',7'-dihydroxybergamottin (6'7'-DHB), epoxybergamottin, and bergamottin] was developed and used to calculate participants' cumulative average and energy-adjusted furocoumarin intake. Multivariate HRs and 95% CIs of the associations between furocoumarin intake and skin cancer risk were estimated using Cox proportional hazards models. Analyses were performed separately in each cohort as well as pooled using a fixed-effects model. RESULTS: Throughout follow-up (1984-2012 in the NHS and 1986-2012 in the HPFS), we identified 1593 melanoma, 4066 SCC, and 28,630 BCC cases. Higher intake of total furocoumarins was associated with an increased risk of BCC; the pooled HR comparing the top with the bottom quintile was 1.16 (95% CI: 1.11, 1.21; P-trend = 0.002). Higher intakes of bergaptol, bergapten, 6'7'-DHB, and bergamottin were also significantly associated with increased BCC risk. No significant associations were found between intake of total furocoumarins and the risks of SCC or melanoma. CONCLUSIONS: Intakes of total furocoumarins as well as some individual furocoumarins were associated with an increased risk of skin cancer, especially BCC, in 2 cohorts of US health professionals.
Authors: Melissa M Melough; Terrence M Vance; Sang Gil Lee; Anthony A Provatas; Christopher Perkins; Abrar Qureshi; Eunyoung Cho; Ock K Chun Journal: J Agric Food Chem Date: 2017-03-29 Impact factor: 5.279
Authors: Melissa M Melough; Sang Gil Lee; Eunyoung Cho; Kijoon Kim; Anthony A Provatas; Christopher Perkins; Min Kyung Park; Abrar Qureshi; Ock K Chun Journal: J Agric Food Chem Date: 2017-06-12 Impact factor: 5.279
Authors: Junichi R Sakaki; Melissa M Melough; Mary B Roberts; Charles B Eaton; Aladdin H Shadyab; Abrar A Qureshi; Ock K Chun; Eunyoung Cho Journal: Cancers (Basel) Date: 2021-04-30 Impact factor: 6.639
Authors: Priyanka Kumar; Danielle Brazel; Julia DeRogatis; Jennifer B Goldstein Valerin; Katrine Whiteson; Warren A Chow; Roberto Tinoco; Justin T Moyers Journal: Cancer Metastasis Rev Date: 2022-04-27 Impact factor: 9.237